Literature DB >> 34008386

Role of surgical treatment in endometriosis.

Maurizio N D'Alterio1, Stefania Saponara2, Gianmarco D'Ancona2, Margherita Russo2, Antonio S Laganà3, Felice Sorrentino4, Luigi Nappi4, Stefano Angioni2.   

Abstract

Endometriosis can take one of three forms depending on its clinical presentation and management: endometriotic ovarian cyst (ovarian endometrioma), superficial or peritoneal endometriosis and deep infiltrating endometriosis (DIE).1Among them, DIE is considered the most aggressive, and the patient is often affected by more than one type together. The therapeutic methodology should not be influenced by a combination of different types of endometriotic lesion. According to the clinical context and the patient's needs, the treatment of this pathology can be medical or surgical. Although medical therapy could improve endometriosis-associated symptoms, it never offers a definite treatment for symptomatic patients, who often require surgical treatment. The rationale behind endometriosis surgical treatment is to achieve the complete removal of all lesions through a one-step surgical procedure; to obtain promising long-term results for pelvic pain, recurrence rate, and fertility; and to protect the functionality of the involved organs. Achieving these results depends on the total removal of the pathology from the pelvis, in an attempt to preserve, as much as possible, the healthy tissues surrounding the site of the disease. The choice of a surgical approach rather than medical therapy is subject to the patient's expectations, such as pregnancy desire, the effectiveness of treatment compared to possible complications, the type of pain and its intensity, and the location and severity of the disease. In this context, surgical management using a multidisciplinary endometriosis team is an important factor for achieving good outcomes.

Entities:  

Year:  2021        PMID: 34008386     DOI: 10.23736/S2724-606X.21.04737-7

Source DB:  PubMed          Journal:  Minerva Obstet Gynecol        ISSN: 2724-606X


  4 in total

1.  Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population.

Authors:  Eider Gómez-Pereira; Jorge Burgos; Rosario Mendoza; Irantzu Pérez-Ruiz; Fátima Olaso; David García; Iker Malaina; Roberto Matorras
Journal:  Reprod Sci       Date:  2022-08-23       Impact factor: 2.924

2.  Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian study.

Authors:  N Berlanda; W Alio; S Angioni; V Bergamini; C Bonin; P Boracchi; M Candiani; G Centini; M N D'Alterio; S Del Forno; A Donati; D Dridi; D Incandela; L Lazzeri; A Maiorana; A Mattei; J Ottolina; A Orenti; A Perandini; F Perelli; I Piacenti; I Pino; M G Porpora; S Scaramuzzino; R Seracchioli; E Solima; E Somigliana; R Venturella; P Vercellini; P Viganò; M Vignali; F Zullo; E Zupi
Journal:  Arch Gynecol Obstet       Date:  2021-10-08       Impact factor: 2.344

3.  Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.

Authors:  Xiaoyan Li; Huaifang Li; Hong Shi; Xiaomao Li; Renfeng Zhou; Dan Lu; Yunlang Cai; Yingfang Zhou; Patrick Cabri; Xiaofeng Shi; Anna Pedret-Dunn; Jinhua Leng
Journal:  Adv Ther       Date:  2022-08-10       Impact factor: 4.070

Review 4.  Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner.

Authors:  Nassir Habib; Giovanni Buzzaccarini; Gabriele Centini; Gaby N Moawad; Pierre-Francois Ceccaldi; Georgios Gitas; Ibrahim Alkatout; Giuseppe Gullo; Sanja Terzic; Zaki Sleiman
Journal:  Prz Menopauzalny       Date:  2022-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.